Literature DB >> 19855424

Nephrotic syndrome: a watershed in the understanding of membranous nephropathy.

Andrew Rees, Renate Kain.   

Abstract

Proof has at last been provided that idiopathic membranous nephropathy is caused by autoantibodies to proteins expressed by podocytes. The discovery that autoantibodies to the M-type secretory phospholipase A2 receptor were present in most individuals affected by the condition opens a new era for the management of membranous nephropathy.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19855424     DOI： 10.1038/nrneph.2009.167

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  9 in total

1.  Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies.

Authors:  Hanna Debiec; Vincent Guigonis; Béatrice Mougenot; Fabrice Decobert; Jean-Philippe Haymann; Albert Bensman; Georges Deschênes; Pierre M Ronco
Journal:  N Engl J Med       Date:  2002-06-27       Impact factor: 91.245

2.  Pathogenesis of membranous glomerulonephritis.

Authors:  D J Evans
Journal:  Lancet       Date:  1974-06-08       Impact factor: 79.321

Review 3.  Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  J Am Soc Nephrol       Date:  2005-03-30       Impact factor: 10.121

Review 4.  Rituximab therapy for membranous nephropathy: a systematic review.

Authors:  Andrew S Bomback; Vimal K Derebail; Julie G McGregor; Abhijit V Kshirsagar; Ronald J Falk; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-11       Impact factor: 8.237

5.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

6.  Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Maria Chiara Sghirlanzoni; Elena Gagliardini; Sara Conti; Flavio Gaspari; Gianfranco Marchetti; Mauro Abbate; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-06       Impact factor: 8.237

7.  Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies.

Authors:  Hanna Debiec; Jeroen Nauta; Florence Coulet; Mirjam van der Burg; Vincent Guigonis; Thierry Schurmans; Emile de Heer; Florent Soubrier; Francoise Janssen; Pierre Ronco
Journal:  Lancet       Date:  2004 Oct 2-8       Impact factor: 79.321

Review 8.  Membranous nephropathy.

Authors:  Claudio Ponticelli
Journal:  J Nephrol       Date:  2007 May-Jun       Impact factor: 3.902

9.  Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions.

Authors:  W HEYMANN; D B HACKEL; S HARWOOD; S G WILSON; J L HUNTER
Journal:  Proc Soc Exp Biol Med       Date:  1959-04
  9 in total
  1 in total

1.  An overview of molecular mechanism of nephrotic syndrome.

Authors:  Juliana Reis Machado; Laura Penna Rocha; Precil Diego Miranda de Menezes Neves; Eliângela de Castro Cobô; Marcos Vinícius Silva; Lúcio Roberto Castellano; Rosana Rosa Miranda Corrêa; Marlene Antônia Reis
Journal:  Int J Nephrol       Date:  2012-07-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.